Hyperglycemia
Conditions
Interventions
Control group:Traditional insulin administration methods
Observational group:Carbohydrate Counting Method for Insulin Dosing
Sponsors
The First Affiliated Hospital of Chongqing Medical University
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: 1.Patients with malignant tumors aged 18-80, who undergo parenteral nutrition therapy after surgery; 2.Diagnosed with Type 2 Diabetes Mellitus according to the World Health Organization (WHO); 3.Glycated hemoglobin (HbA1c) levels are greater than or equal to 7% and less than or equal to 10%.
Exclusion criteria
Exclusion criteria: 1.Type 2 diabetes during the lactation period; 2.Type 2 diabetes complicated by acute diabetes-related complications; 3.Complicated by severe infectious diseases, and impairment of liver and/or kidney function; 4.Complicated by senile dementia and psychiatric behavioral abnormalities; 5.Transferred directly to the Intensive Care Unit (ICU) after surgery; 6.Body Mass Index (BMI) is less than 17.0; 7.Heart failure with New York Heart Association (NYHA) Class III-IV heart function; 8.Acute Myocardial Infarction; 9.Postoperatively, during parenteral nutrition therapy, chemotherapy drugs, glucocorticoids, targeted therapies, and immune checkpoint inhibitors are used concurrently.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The average capillary glucose value during postoperative parenteral nutrition infusion; | — |
Secondary
| Measure | Time frame |
|---|---|
| The incidence rate of short-term complications within 30 days postoperatively;The proportion of time that capillary glucose levels are within the target range of 7.8 to 13.9 mmol/L, known as Time in Range (TIR).;Average daily insulin dosage;Average daily carbohydrate intake;Average length of hospital stay;Average hospitalization costs;Postoperative glycated hemoglobin levels at 3 months;Unplanned readmission within 30 days;Coefficient of Variation;The proportion of time that capillary glucose values are above (TAR) or below (TBR) the target range of 7.8 to 13.9 mmol/L.; | — |
Countries
China
Contacts
Public ContactZhiping Liu
The First Affiliated Hospital of Chongqing Medical University
Outcome results
None listed